Universal Prophylactic Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.78 Cr
as on 16-11-2024
- Revenue 59.69%
(FY 2023)
- Profit 44.11%
(FY 2023)
- Ebitda 67.52%
(FY 2023)
- Net Worth 18.06%
(FY 2023)
- Total Assets -10.01%
(FY 2023)
About Universal Prophylactic
The Corporate was formerly known as Deogiri Latex Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹8.78 Cr.
Shirish Boralkar and Sushma Boralkar serve as directors at the Company.
- CIN/LLPIN
U99999MH2000PTC128020
- Company No.
128020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Universal Prophylactic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shirish Boralkar  | Managing Director | 01-Aug-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushma Boralkar | Director | 10-Jul-2007 | Current |
Financial Performance of Universal Prophylactic.
Universal Prophylactic Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.69% increase. The company also saw a substantial improvement in profitability, with a 44.11% increase in profit. The company's net worth Soared by an impressive increase of 18.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Prophylactic?
In 2023, Universal Prophylactic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Redolence Care Private LimitedActive 13 years 3 monthsShirish Boralkar and Sushma Boralkar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jan 2022 | ₹6.86 Cr | Open |
Indian Overseas Bank Creation Date: 31 Dec 2007 | ₹1.70 M | Open |
Indian Overseas Bank Creation Date: 21 Dec 2002 | ₹1.75 Cr | Open |
How Many Employees Work at Universal Prophylactic?
Universal Prophylactic has a workforce of 8 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Prophylactic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Prophylactic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
